Hubert Wolfe Award

This award, established in memory of Dr. Hubert Wolfe, will be awarded annually at the discretion of the Society to honor an outstanding paper in the field of endocrine pathology published during the previous year by a pathologist in training.

Dr. Wolfe was a founding member of the Endocrine Pathology Society and the Society’s first President. He was a visionary pathologist who pioneered the development of both immunohistochemistry and diagnostic molecular pathology. His classic paper on the clinical, pathological and immunohistochemical features of C-cell hyperplasia and its relationship to medullary thyroid carcinoma was published in 1973. That seminal contribution provided the foundations for understanding of early thyroid cancer development in patients with type 2 multiple endocrine neoplasia syndromes. Dr. Wolfe established one of the world’s first diagnostic molecular pathology laboratories in the in the early 1980’s and was one of the first researchers to utilize in situ hybridization for studies of endocrine tumors and their precursor lesions. He used his laboratory to train dozens of young pathologists who now hold respected positions in the United States, Europe and Japan.

The call for nominations is typically announced in the December issue of Endocrine Pathology Journal. Nominations should be emailed at [email protected] and will be reviewed by the Wolfe award committee. The award and accompanying prize will be awarded at the Society’s annual meeting.

The Wolfe Award Committee:

Ronald A. DeLellis, M.D.
Lifespan Academic Medical Center
Arthur S. Tischler, M.D.
Tufts Medical Center
Rony Ghossein, M.D.
Memorial Sloan Kettering Cancer Center
Ozgur Mete, M.D.
University Health Network